InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
0.00%
)
US TECH 100
17,678.80
(
-0.25%
)
Dow Jones
39,431.51
(
0.00%
)
Brent Oil
82.63
(
-0.70%
)
Bitcoin
61,566.00
(
-2.12%
)
Post# of 63
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NASDAQ2020

Send PM Follow Ignore
Followers 188
Posts 28689
Boards Moderated 1
Alias Born 08/29/2012

NASDAQ2020

Re: None

Monday, 09/25/2023 7:02:08 AM

Monday, September 25, 2023 7:02:08 AM

Post# of 63
X 1. In house marketing and distribution: Kirkov
X 2. Generic OxyContin- FIRST TO FILE Sept 25, 2023- $720 Million
—3. Generic Concerta- $1.2 BILLION
—4. Generic Vyvanse- $5.1 BILLION
—5. Vigabatrin
—6. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
—7.Patented Unique ADF (w/o naltrexone)-- NDA
—8. Mikah monster
—9. Undisclosed
—10.:Antimetabolite ANDA- Methotrexate -$600 Million
—11. Undisclosed Antimetabolite ANDA- $42 Million
—12. Full ownership of Adderall XR
—13. Prasco/Burel Adderall agreement
—14. Dexcel partnership approval by Israeli health for European distribution
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up